Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis

被引:16
作者
Amini-Salehi, Ehsan [1 ]
Hassanipour, Soheil [1 ]
Joukar, Farahnaz [1 ]
Daryagasht, Amir Ali [1 ]
Khosousi, Mohammad-Javad [1 ]
Aleali, Maryam Sadat [1 ]
Ansar, Malek Moien [2 ]
Heidarzad, Forough [1 ]
Abdzadeh, Elham [1 ]
Vakilpour, Azin [3 ]
Mansour-Ghanaei, Fariborz [1 ]
机构
[1] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran
[2] Guilan Univ Med Sci, Sch Med, Dept Biochem, Rasht, Iran
[3] Guilan Univ Med Sci, Rasht, Iran
关键词
Epidemiology; Non-alcoholic Fatty Liver Disease (NAFLD); Risk Factors; Systematic Review; Meta-analysis; Iran; PLATELET RATIO INDEX; TYPE-2; DIABETES-MELLITUS; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; ALANINE AMINOTRANSFERASE; WAIST CIRCUMFERENCE; CARDIOVASCULAR RISK; HEPATIC STEATOSIS; DIETARY PATTERNS;
D O I
10.5812/hepatmon-131523
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Context: Non-alcoholic fatty liver disease (NAFLD) is progressing considerably worldwide. Identifying the risk factors of NAFLD is a Methods: In November 2022, two independent researchers studied seven databases, including PubMed, ISI/WoS, ProQuest, Scopus, SID, Magiran, and Google Scholar, and reference list of relevant articles, searching studies that assessed NAFLD risk factors in the Iranian adult population. Heterogeneity between studies was assessed by Cochran's test and its composition using I2 statistics. A random-effects model was used when heterogeneity was observed; otherwise, a fixed-effects model was applied. Egger's regression test and Trim-and-Fill analysis were used to assess publication bias. Comprehensive Meta-analysis software (version 3) was used for Results: The results of this study showed significant associations between NAFLD with age (n = 15, odds ratio (OR) = 2.12, 95% CI: 1.79 - 2.51), body mass index (n = 46, OR = 5.00, 95% CI: 3.34 - 7.49), waist circumference (n = 20, OR = 6.37, 95% CI: 3.25 -12.48), waist-to-hip ratio (n =17, OR = 4.72, 95% CI: 3.93 - 5.66), total cholesterol (n = 39, OR = 1.80, 95% CI: 1.52 - 2.13), high-density lipoprotein (n = 37, OR = 0.53, 95% CI: 0.44 - 0.65), low-density lipoprotein (n = 31, OR = 1.68, 95% CI: 1.38 - 2.05), triglyceride (n = 31, OR = 3.21, 95% CI: 2.67 3.87), alanine aminotransferase (n = 26, OR = 4.06, 95% CI: 2.94 - 5.62), aspartate aminotransferase (n = 27, OR = 2.16, 95% CI: 1.50 -3.12), hypertension (n =13, OR = 2.53, 95% CI: 2.32 - 2.77), systolic blood pressure (n =13, OR = 1.83, 95% CI: 1.53 - 2.18), diastolic blood pressure (n =14, OR = 1.80, 95% CI: 1.48 - 2.20), fasting blood sugar (n =31, OR = 2.91, 95% CI: 2.11- 4.01), homeostatic model assessment for insulin resistance (n = 5, OR = 1.92, 95% CI: 1.48 - 2.59), diabetes mellitus (n =15, OR = 3.04, 95% CI: 2.46 -3.75), metabolic syndrome (n = 10, OR = 3.56, 95% CI: 2.79 - 4.55), and physical activity (n = 11, OR = 0.32, 95% CI: 0.24 - 0.43) (P < 0.05).Conclusions: In conclusion, several factors are significantly associated with NAFLD. However, anthropometric indices had the strongest relationship with NAFLD in the Iranian adult population.
引用
收藏
页数:18
相关论文
共 199 条
[1]   Nonalcoholic fatty liver disease [J].
Adams, LA ;
Angulo, P ;
Lindor, KD .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (07) :899-905
[2]  
Adibi Atoosa, 2017, Adv Biomed Res, V6, P47, DOI 10.4103/2277-9175.204590
[3]  
Agarwal Rajiv, 2005, BMC Nephrol, V6, P13
[4]  
Alavian SM, 2008, Iranian Journal of Endocrinology and Metabolism, V10, P99
[5]  
Aller R, 2015, EUR REV MED PHARMACO, V19, P3118
[6]  
Amirkalali B, 2014, IRAN J PUBLIC HEALTH, V43, P1275
[7]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[8]  
[Anonymous], 2017, Checklist for Analytical Cross-Sectional Studies
[9]   Epidemiology and Natural History of Non-Alcoholic Steatohepatitis [J].
Argo, Curtis K. ;
Caldwell, Stephen H. .
CLINICS IN LIVER DISEASE, 2009, 13 (04) :511-+
[10]   Recent insights on the role of cholesterol in non-alcoholic fatty liver disease [J].
Arguello, Graciela ;
Balboa, Elisa ;
Arrese, Marco ;
Zanlungo, Silvana .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2015, 1852 (09) :1765-1778